期刊文献+

11年间烧伤病房铜绿假单胞菌耐药率调查 被引量:22

Investigation on the drug resistance of Pseudomonas aeruginosa in our burn ward in the past 11 years
原文传递
导出
摘要 目的 总结笔者单位烧伤病房近 11年来抗生素使用和铜绿假单胞菌耐药的情况变化 ,为今后合理使用抗生素提供参考。 方法 调查 1991~ 2 0 0 1年烧伤病房细菌的流行病学 ,从抗生素成人药物平均日剂量 (DDDs)和用药天数排序中了解铜绿假单胞菌的耐药变化。  结果  (1)病房菌以金黄色葡萄球菌 (10 .5 3%~ 34.4 0 % )和铜绿假单胞菌 (75 .6 6 %~ 11.4 7% )为主。 (2 )使用率较高的抗生素有青霉素、阿米卡星、万古霉素、亚胺培南 西司他丁钠盐和头孢他啶。 (3)铜绿假单胞菌对抗生素的耐药率逐渐上升 ,依次为 :哌拉西林 (41.5 7%~ 10 0 .0 0 % )、亚胺培南 西司他丁钠盐 (36 .36 %~98.4 6 % )、头孢他啶 (2 3.4 6 %~ 97.85 % )、阿米卡星 (13.16 %~ 10 0 .0 0 % )、环丙沙星 (6 .90 %~ 10 0 .0 0 % )。 结论 铜绿假单胞菌耐药性增加 ,主要与广泛应用抗生素有关。 Objective To analyze the use of antibiotics and the drug resistance of Pseudomonas aeruginosa in the burn ward of our hospital in the past 11 years, so as to optimize the use of antibiotics in the future. Methods Bacterial epidemiology during 1991~2001 in our burn ward was investigated. The change of the drug resistance of Pseudomonas aeruginosa was observed by defined daily dose (DDD) of antibiotics in adult patients and by the ranking of antibiotic administration days. Results (1)Staphylococcus aureus (10.53%~34.40%) and Pseudomonas aeruginosa (75.66%~11.47%) were dominant in our burn ward. (2)Predominant antibiotics used included Penicillin, Amikacin, Vancomycin, Imipenem and Ceftazidime.(3)There was increasing drug resistance of Pseudomonas aeruginosa to the following antibiotics ranking in following order:Piperacillin ( 41.57%~100.00%), Imipenem( 36.36%~98.46%), Ceftazidime (23.46%~97.85%), Amikacin(13.16%~100.00%) and ciprofloxacin (6.90%~100.00%).Conclusion There was increasing drug resistance of Pseudomonas aeruginosa to all antibiotics, which might be related to antibiotic abuse.
出处 《中华烧伤杂志》 CAS CSCD 2004年第1期6-9,共4页 Chinese Journal of Burns
关键词 烧伤 铜绿假单胞菌 耐药 抗生素 流行病学 Burn Pseudomonas aeruginosa Drug resistance,microbial Antibiotics
  • 相关文献

参考文献5

二级参考文献10

  • 1许伟石.烧伤创面细菌生态学变化与抗生素选择.全国烧伤感染及并发症专题研讨会论文汇编[M].,1995.111-113.
  • 2陈民钧,中华医学检验杂志,1993年,6卷,325页
  • 3马纪平,中华医学检验杂志,1991年,14卷,233页
  • 4National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing;Ninth Informational Supplement,NCCLS documents M100-S9[S].Pennsylvania:NCCLS,1999.1-103.
  • 5Levy S.Multidrug resistance-a sign of the times[J].N Engl J Med,1998,338:1376-1378.
  • 6Witte W.Antibiotic resistance in Gram-positive bacteria:epidemiological aspects[J].J Antimicrob Chemother,1999,44Topic A:1-9.
  • 7Andrews J,Ashby J,Jevons G,et al.Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997[J].J Antimicrob Chemother,1999,43:689-698.
  • 8Schmitz FJ,Verhoef J,Fluif AC,et al.Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY Surveillance Propramme[J].J Antimicrob Chemother,1999,41:783-792.
  • 9申正义,孙自镛,王洪波.武汉地区临床分离菌耐药性监测[J].中华内科杂志,1998,37(7):440-443. 被引量:42
  • 10汪复,吴溰,朱德妹.1998年上海地区细菌耐药性监测[J].中华内科杂志,1999,38(11):729-732. 被引量:133

共引文献150

同被引文献175

引证文献22

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部